title: Mechanisms of primary axonal damage in a viral model of multiple sclerosis.
abstract: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Recent studies have demonstrated that significant axonal injury also occurs in MS patients and correlates with neurological dysfunction, but it is not known whether this neuronal damage is a primary disease process, or occurs only secondary to demyelination. In the current studies, neurotropic strains of mouse hepatitis virus (MHV) that induce meningitis, encephalitis, and demyelination in the CNS, an animal model of MS, were used to evaluate mechanisms of axonal injury. The pathogenic properties of genetically engineered isogenic spike protein recombinant demyelinating and nondemyelinating strains of MHV were compared. Studies demonstrate that a demyelinating strain of MHV causes concomitant axonal loss and macrophage-mediated demyelination. The mechanism of axonal loss and demyelination in MHV infection is dependent on successful transport of virus from gray matter to white matter using the MHV host attachment spike glycoprotein. Our data show that axonal loss and demyelination can be independent direct viral cytopathic events, and suggest that similar direct axonal damage may occur in MS. These results have important implications for the design of neuroprotective strategies for CNS demyelinating disease, and our model identifies the spike protein as a therapeutic target to prevent axonal transport of neurotropic viruses.
authors.affiliation: Department of Neurology and Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA. dassarmaj@iiserkol.ac.in
authors.forename: Jayasri
authors.initials: J
authors.lastname: Das Sarma
authors.forename: Lawrence C
authors.initials: LC
authors.lastname: Kenyon
authors.forename: Susan T
authors.initials: ST
authors.lastname: Hingley
authors.forename: Kenneth S
authors.initials: KS
authors.lastname: Shindler
mesh_terms: D000818:Animals; D001369:Axons / Q000378:metabolism / Q000473:pathology* / Q000821:virology*; D002478:Cells, Cultured; D004195:Disease Models, Animal; D018836:Inflammation Mediators / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009103:Multiple Sclerosis / Q000378:metabolism / Q000473:pathology* / Q000821:virology*; D006517:Murine hepatitis virus / Q000235:genetics / Q000472:pathogenicity; D009186:Myelin Sheath / Q000378:metabolism / Q000473:pathology / Q000821:virology; D009410:Nerve Degeneration / Q000378:metabolism / Q000473:pathology / Q000821:virology
chemical_list: D018836:Inflammation Mediators
references.citation: Virology. 2001 Jan 20;279(2):371-4
references.pmid: 11162792
references.citation: N Engl J Med. 1998 Jan 29;338(5):278-85
references.pmid: 9445407
references.citation: J Gen Virol. 1988 Dec;69 ( Pt 12):2939-52
references.pmid: 3058868
references.citation: Mult Scler. 2001 Aug;7(4):221-6
references.pmid: 11548980
references.citation: J Virol. 1994 Sep;68(9):5403-10
references.pmid: 7520090
references.citation: Curr Opin Neurol. 2001 Jun;14(3):259-69
references.pmid: 11371747
references.citation: J Virol. 2001 Jul;75(13):6115-20
references.pmid: 11390613
references.citation: J Virol. 2008 Jun;82(11):5519-26
references.pmid: 18385249
references.citation: Microbes Infect. 2001 May;3(6):475-9
references.pmid: 11377209
references.citation: J Virol. 1997 Feb;71(2):1688-91
references.pmid: 8995701
references.citation: Virology. 1998 May 10;244(2):483-94
references.pmid: 9601516
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4659-63
references.pmid: 9114047
references.citation: Brain. 1997 Mar;120 ( Pt 3):393-9
references.pmid: 9126051
references.citation: J Neuropathol Exp Neurol. 1997 Nov;56(11):1262-8
references.pmid: 9370237
references.citation: J Virol. 2003 Jan;77(2):830-40
references.pmid: 12502799
references.citation: Nat Rev Neurosci. 2002 Apr;3(4):291-301
references.pmid: 11967559
references.citation: J Virol. 2008 Sep;82(17):8882-6
references.pmid: 18579591
references.citation: Epidemiology. 2001 May;12(3):301-6
references.pmid: 11337603
references.citation: Curr Opin Neurol. 1999 Jun;12(3):295-302
references.pmid: 10499174
references.citation: Virology. 1992 Nov;191(1):517-22
references.pmid: 1413526
references.citation: Brain. 2000 Feb;123 ( Pt 2):308-17
references.pmid: 10648438
references.citation: J Neurol Sci. 1984 Jan;63(1):63-74
references.pmid: 6321668
references.citation: J Virol. 1994 May;68(5):2915-28
references.pmid: 8151762
references.citation: EMBO J. 2002 May 1;21(9):2076-86
references.pmid: 11980704
references.citation: Neurobiol Aging. 2006 Feb;27(2):293-305
references.pmid: 16002188
references.citation: Brain Res Bull. 1996;41(6):327-33
references.pmid: 8973836
references.citation: J Neurovirol. 2002 Oct;8(5):381-91
references.pmid: 12402164
references.citation: Neurology. 2001 Oct 9;57(7):1248-52
references.pmid: 11591844
references.citation: Am J Pathol. 2000 Jul;157(1):267-76
references.pmid: 10880396
references.citation: J Virol. 2002 Dec;76(23):11819-26
references.pmid: 12414924
references.citation: J Neurol Sci. 1990 Apr;96(1):103-23
references.pmid: 2351985
references.citation: Neurology. 1984 May;34(5):597-603
references.pmid: 6324031
references.citation: Am J Pathol. 2003 Apr;162(4):1259-69
references.pmid: 12651618
references.citation: Virology. 1997 Jan 6;227(1):215-9
references.pmid: 9007076
references.citation: J Virol. 2001 Mar;75(5):2452-7
references.pmid: 11160748
references.citation: Acta Neuropathol. 1997 Feb;93(2):184-9
references.pmid: 9039467
references.citation: J Virol. 1985 Dec;56(3):912-20
references.pmid: 2999444
references.citation: J Virol. 2000 Oct;74(19):9206-13
references.pmid: 10982367
references.citation: Springer Semin Immunopathol. 2002;24(2):105-25
references.pmid: 12503060
references.citation: J Virol. 1993 Jan;67(1):1-8
references.pmid: 8380065